Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px
Document › Details

IMD Natural Solutions GmbH. (8/31/15). "Press Release: IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives Technologies". Dortmund & Taizhou City.

Organisations Organisation IMD Natural Solutions GmbH (INS)
  Group IMD Natural Solutions (INS) (Group)
  Organisation 2 Zhejiang Hisun Pharmaceutical Co., Ltd. (Hisun, SHA:600267)
Products Product phytopharmaceutical
  Product 2 drug discovery
Index terms Index term IMD Natural Solutions–Hisun Pharmaceutical: investment, 201508 equity investment €4m as part of collab with Zhejiang Hisun Pharmaceutical Co Ltd
  Index term 2 Hisun Pharmaceutical–IMD Natural Solutions: drug discovery, 201508– collab using IMD natural product lead discovery platform incl €4m investment
Persons Person Henkel, Thomas (IMD Natural Solutions 201508 Managing Director + Co-Founder + Imax Discovery before Bayer)
  Person 2 Gabriel, Raimund (MC Services 1999–201101– Founder + CEO)

IMD Natural Solutions GmbH (INS), a natural product company, today announced a collaboration with Zhejiang Hisun Pharmaceutical Co., Ltd. (Hisun; SHA:600267) under which INS receives a EUR4 million equity investment and provides Hisun access to INS' unique natural product lead discovery platform for antimicrobials and antioxidants for the food, beverage and personal care industries. Furthermore, INS will benefit from Hisun's production know-how and capabilities.

The investment paves the way for INS to further develop and commercialize its innovative antimicrobial preservation product for use in food, beverage and personal care applications. It is a new, fermentation-based all-natural agent with superior efficacy against yeasts, molds and other microbial strains and has shown bioactivity against microbial organisms that have adapted to current preservative agents. The collaboration provides Hisun access to INS' natural product databases and technology for the identification and development of suitable active natural ingredients for various life science applications.

"The investment by Hisun into INS and our access to Hisun's production know-how and capabilities are an important step in driving our core product towards market entry," said Dr. Thomas Henkel, Managing Director of INS.

"The combination of INS's natural product platform and product candidates with Hisun's production know-how creates a unique platform for the development and commercialization of new, innovative products and thus strengthens our market position and pipeline potential substantially," said Mr. Bai Hua, President and CEO of Hisun.

About IMD Natural Solutions GmbH

IMD Natural Solutions GmbH (INS) was founded in 2012 in Dortmund, Germany. The management has more than 20 years of experience in the discovery and development of active compounds derived from natural products. INS owns extensive proprietary natural product and genetic source collections, a unique technology platform as well as broad chemical and biological databases. INS develops and commercializes innovative ingredients - with a special focus on preservative agents - derived from totally natural sources. The main target markets are in the food, beverages and personal care industries.

About Zhejiang Hisun Pharmaceuticals

Founded in 1956, the vision of Zhejiang Hisun Pharmaceuticals Co., Ltd. (stock code 600267) is to become "a widely respected international pharmaceutical company" by advancing its mission of "persisting in pharmaceutical innovation for the benefit of human beings." The Company focuses on the integration of pharmaceutical research and development (R&D) with production resources in order to provide its global customers with outstanding products and services. To date, over 40 of the Company's products have passed certification by the FDA (U.S.), EDQM (EU), TGA (Australia), KFDA (Korea), etc., and are sold in more than 30 countries worldwide. To learn more about Hisun, please visit


Dr. Thomas Henkel, Managing Director
IMD Natural Solutions GmbH
Phone: +49-231-9742-7400

Wei Zhang, Secretary of board
Zhejiang HISUN Pharmaceutical Co., Ltd.
Phone: +86-0576-88827809

Raimund Gabriel, Managing Partner
MC Services AG
Phone: +49-89-210228-30

Record changed: 2019-06-09


Picture Fairtec GmbH Worldwide Event Solutions 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top